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Introduction
Store-operated calcium entry (SOCE) generates sustained and 
oscillatory cytosolic Ca2+ signals that regulate diverse cellular 
functions such as transcription, differentiation, motility, and se-
cretion (Parekh and Putney, 2005; Hogan et al., 2010; Lewis, 
2011). The most well-characterized store-operated channel is 
the Ca2+ release-activated Ca2+ (CRAC) channel, and defects in 
its function cause severe combined immunodeficiency (Feske et 
al., 2006, 2010) as well as deficits in muscle development and 
function (Stiber et al., 2008; Darbellay et al., 2010; Wei-LaPi-
erre et al., 2013), platelet function (Varga-Szabo et al., 2011), 
and skin homeostasis (Vandenberghe et al., 2013).
SOCE is activated by the depletion of ER Ca2+ stores, 
typically upon activation of cell surface receptors. The stromal 
interaction molecule (STIM) family of ER Ca2+ sensors (STIM1 
and STIM2; Liou et al., 2005; Roos et al., 2005; Zhang et al., 
2005) and the Orai Ca2+ channels (Orai1, 2, and 3; Feske et al., 
2006; Vig et al., 2006) are key molecular mediators of SOCE 
(Cahalan, 2009; Hogan et al., 2010; Lewis, 2011). Store deple-
tion triggers oligomerization (Stathopulos et al., 2006; Liou et 
al., 2007; Covington et al., 2010) and conformational rearrange-
ments of STIM proteins (Muik et al., 2011). These rearrange-
ments expose the C-terminal polybasic domain, which interacts 
with phosphatidylinositol 4,5-bisphosphate in the plasma mem-
brane (PM) and drives STIM accumulation at ER–PM junctions 
(Wu et al., 2006; Liou et al., 2007; Ercan et al., 2009; Park et 
al., 2009). Although STIM1 and STIM2 respond similarly to 
store depletion, STIM2 differs from STIM1 in being partially 
localized at ER–PM junctions even in store-replete cells, likely 
as a result of its lower affinity for ER Ca2+ relative to STIM1 
(Brandman et al., 2007; Zheng et al., 2008). At ER–PM junc-
tions STIM proteins directly bind to and trap Orai channels 
(Park et al., 2009; Wu et al., 2014) through their CRAC activa-
tion domains (CADs; also known as SOAR [STIM1 Orai1 acti-
vation region] or CCb9; Kawasaki et al., 2009; Park et al., 2009; 
Yuan et al., 2009). STIM binding to Orai opens the channel by a 
nonlinear process that is highly sensitive to binding stoichiom-
etry (Hoover and Lewis, 2011; Li et al., 2011).
The amplitude and dynamics of SOCE-mediated Ca2+ sig-
nals are important factors in shaping Ca2+-dependent responses 
such as gene expression (Dolmetsch et al., 1997, 1998). Several 
mechanisms that affect the magnitude of SOCE have been iden-
tified, such as transcriptional regulation (Ritchie et al., 2010), 
posttranslational modifications (Smyth et al., 2009; Hawkins et 
al., 2010; Pozo-Guisado et al., 2010), and accessory proteins 
Store-operated calcium entry (SOCE) regulates a wide variety of essential cellular functions. SOCE is mediated by STIM1 
and STIM2, which sense depletion of ER Ca2+ stores and activate Orai channels in the plasma membrane. Although the 
amplitude and dynamics of SOCE are considered important determinants of Ca2+-dependent responses, the underlying 
modulatory mechanisms are unclear. In this paper, we identify STIM2β, a highly conserved alternatively spliced isoform 
of STIM2, which, in contrast to all known STIM isoforms, is a potent inhibitor of SOCE. Although STIM2β does not by 
itself strongly bind Orai1, it is recruited to Orai1 channels by forming heterodimers with other STIM isoforms. Analysis 
of STIM2β mutants and Orai1-STIM2β chimeras suggested that it actively inhibits SOCE through a sequence-specific 
allosteric interaction with Orai1. Our results reveal a previously unrecognized functional flexibility in the STIM protein 
family by which alternative splicing creates negative and positive regulators of SOCE to shape the amplitude and dy-
namics of Ca2+ signals.
Alternative splicing converts STIM2 from an activator 
to an inhibitor of store-operated calcium channels
Anshul Rana,1,4 Michelle Yen,4,5 Amir Masoud Sadaghiani,2,6 Seth Malmersjö,3 Chan Young Park,7 
Ricardo E. Dolmetsch,2,6 and Richard S. Lewis4
1Graduate Program in Biochemistry, 2Department of Neurobiology, 3Department of Chemical and Systems Biology, 4Department of Molecular and Cellular Physiology, and 
5Graduate Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305
6Novartis Institutes for Biomedical Research, Boston, MA 02139
7Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 689-798, South Korea
© 2015 Rana et al. This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publication date (see 
http://www.rupress.org/terms). After six months it is available under a Creative Commons 
License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at 
http://creativecommons.org/licenses/by-nc-sa/3.0/).
Correspondence to Chan Young Park: cypark@unist.ac.kr; Ricardo E. Dolmetsch: 
ricardo.dolmetsch@novartis.com; or Richard S. Lewis: rslewis@stanford.edu
Abbreviations used in this paper: CAD, CRAC activation domain; CRAC, Ca2+ 
release-activated Ca2+; DVF, divalent-free; FRET, Förster resonance energy 
transfer; NFAT, nuclear factor of activated T cells; PDBu, phorbol 12,13-dibu-
tyrate; PM, plasma membrane; ROI, region of interest; SOCE, store-operated 
calcium entry; STIM, stromal interaction molecule; Tg, thapsigargin.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
 o
n
 July 2, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published June 1, 2015
http://jcb.rupress.org/content/suppl/2015/05/25/jcb.201412060.DC1.html 
Supplemental Material can be found at:
JCB • VOLUME 209 • NUMBER 5 • 2015654
(Srikanth et al., 2010; Palty et al., 2012; Miao et al., 2013). 
Significantly, all of these mechanisms modulate the activity of 
STIM proteins without altering their role as activators of SOCE.
A largely unexplored mechanism with the potential to 
qualitatively alter STIM function is alternative splicing. Recent 
studies have shown that most, if not all, multiexonal proteins 
undergo alternative splicing (Kornblihtt et al., 2013). With 
more than 10 annotated exons, both STIM1 and STIM2 are 
thus likely to exist as multiple splice isoforms with varying 
properties. The only characterized splice variant in the STIM 
family thus far is STIM1L, which includes an actin binding 
site that prelocalizes it near ER–PM junctions in striated mus-
cle and may thereby facilitate rapid SOCE kinetics (Darbel-
lay et al., 2011; Horinouchi et al., 2012). All presently known 
STIM isoforms, including STIM1L, serve as activators of Ca2+ 
influx through Orai channels.
In this study, we describe a novel STIM2 splice isoform, 
STIM2β, which inhibits Orai function. STIM2β splicing is evo-
lutionarily conserved and developmentally regulated. It con-
tains an eight-residue insert in its CAD that disrupts binding to 
Orai. However, heterodimerization with other STIM isoforms 
recruits STIM2β to CRAC channels where it inhibits Ca2+ influx 
through an allosteric mechanism. Our results establish STIM2β 
as the first STIM isoform that inhibits Orai channels and intro-
duce alternative splicing as a means of controlling the balance 
between SOCE activators and inhibitors, thereby tuning the 
magnitude and time course of calcium entry.
Results
STIM2β is a novel and widely expressed 
STIM2 splice isoform
Our attempts to amplify portions of the STIM2 cytosolic domain 
from cDNA generated from several cell lines unexpectedly pro-
duced a doublet of bands when visualized on a standard agarose 
gel (Fig. 1 A). Sequencing of the higher molecular weight band 
revealed that it corresponded to a novel splice isoform formed 
by in-frame splicing of exon 9 of the STIM2 gene (Fig. 1 B). We 
named the new isoform STIM2β and will refer hereafter to the 
conventional isoform (without exon 9) as STIM2α. STIM2β is 
widely expressed across tissues, as shown by analysis of human 
tissue RNA samples (Fig. 1 C).
STIM2 exon 9 is present in most mammalian species and is 
highly conserved at the amino acid level (Fig. 1 D and Fig. S1 A), 
suggesting that its alternative splicing may serve a physiological 
function. To examine this possibility, we asked whether STIM2β 
splicing is developmentally regulated, using the serum withdraw-
al-induced myogenic differentiation of C2C12 myoblasts as a 
model system (Burattini et al., 2004). Quantitative RT-PCR anal-
ysis showed a slight reduction in STIM2α mRNA levels during 
the first 48 h of differentiation into myotubes; however, STIM2β 
mRNA levels increased significantly over this period, generating 
an approximately fivefold increase in the STIM2β/STIM2α ratio 
(Fig. 1 E). Up-regulation of STIM2β splicing was also observed 
during neuronal differentiation in vitro (unpublished data). These 
results show that STIM2β splicing is regulated and support the 
possibility of a physiological function.
The in-frame splicing of exon 9 inserts eight amino acids 
(the “2β insert”) into the highly conserved CAD of STIM2 (Fig. 
1, F and G). The CAD region is critical for binding and activat-
ing Orai1 (Park et al., 2009) as well as stabilizing STIM dimers 
and oligomers (Covington et al., 2010; Yang et al., 2012). We 
used homology modeling (Bennett-Lovsey et al., 2008) based 
on the STIM1-CAD crystal structure (Yang et al., 2012), as well 
as de novo structure prediction (Lupas et al., 1991), to predict 
the effect of the 2β insert on CAD structure. While the predicted 
structure of STIM2α-CAD is quite similar to that of STIM1-
CAD, the 2β insert significantly disrupts the helical topology of 
STIM2β-CAD (Fig. 1 H and Fig. S1 B). In particular, the model 
predicts that the helical stretch of basic residues (KIKKKR; 
Fig. 1 H, highlighted in purple) known to play a critical role in 
binding to Orai1 (Calloway et al., 2009, 2010; Korzeniowski 
et al., 2010) is likely to be disrupted in STIM2β, whereas the 
regions responsible for STIM–STIM dimerization (Yang et al., 
2012; Stathopulos et al., 2013) may remain intact.
STIM2β inhibits Orai1-mediated Ca2+ influx
To determine the functional consequences of the 2β insert, we 
compared the effects of STIM2β and STIM2α on resting cyto-
solic Ca2+ ([Ca2+]i) and ER Ca2+ ([Ca2+]ER) levels in HEK293T 
cells. STIM2α overexpression led to a large increase in rest-
ing [Ca2+]i as reported previously (Fig. 2, A and B; Brandman 
et al., 2007). In contrast, overexpression of STIM2β caused a 
small but significant decrease. In cells expressing the Förster 
resonance energy transfer (FRET)–based [Ca2+]ER sensor 
T1ER (Bandara et al., 2013), coexpression of STIM2β with 
Orai1 caused a significant decrease in [Ca2+]ER (Fig. 2, C and 
D). In this case, a comparison with STIM2α was not possible, 
as STIM2α overexpression for the extended period of time 
required for T1ER coexpression led to large-scale cell death, 
presumably caused by a prolonged increase in [Ca2+]i (unpub-
lished data). These experiments indicate that, in direct contrast 
to STIM2α, STIM2β negatively regulates the resting levels of 
both cytosolic and ER Ca2+.
The effect of STIM2α on [Ca2+]i and [Ca2+]ER arises from 
its ability to activate SOCE through interactions with Orai1 
(Brandman et al., 2007). We applied thapsigargin (Tg) to deplete 
Ca2+ stores and examine the effects of STIM2α and STIM2β on 
SOCE in HEK293 cells overexpressing Orai1 (Fig. 2 E). With 
Orai1 expression alone, reintroduction of extracellular Ca2+ 
after store depletion evoked a large increase in [Ca2+]i reflect-
ing activation of SOCE by endogenous STIMs. Coexpression 
of STIM2α with Orai1 enhanced the level of SOCE, in addition 
to causing a large increase in resting [Ca2+]i. In contrast, overex-
pression of STIM2β with Orai1 strongly inhibited SOCE to lev-
els below those seen with Orai1 overexpression alone (Fig. 2 E).
To further confirm the inhibitory effects of STIM2β, we 
examined SOCE-activated signaling through the transcription 
factor nuclear factor of activated T cells (NFAT). NFAT-medi-
ated transcription requires elevated [Ca2+]i as well as PKC ac-
tivity (Rao et al., 1997). HEK293T cells transfected with an 
NFAT-luciferase reporter and treated with phorbol 12,13-dib-
utyrate (PDBu) to activate PKC showed a strong up-regulation 
of luciferase expression after store depletion with Tg (Fig. 2 F). 
Overexpression of STIM2α increased NFAT-driven luciferase 
activity in PDBu-treated cells even in the absence of Tg (Fig. 2 
F), as expected from the large increase in basal [Ca2+]i seen in 
Fig. 2 E. In contrast, overexpression of STIM2β strongly inhib-
ited the Tg-mediated increase in luciferase activity, consistent 
with its inhibition of SOCE in Fig. 2 E. Collectively, the results 
shown in Fig. 2 indicate that unlike STIM2α, STIM2β strongly 
inhibits SOCE generated by endogenous STIM and Orai.
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Figure 1. STIM2β is a novel, widely expressed STIM2 splice isoform. (A, top) cDNA from Jurkat and C2C12 cells was amplified using primers targeting 
the CAD domain of STIM2. The topmost band represents the STIM2β splice isoform. (bottom) Primers targeting GAPDH were used as a positive control. 
(B) Partial schematic of the STIM2 genomic locus. In-frame inclusion of exon 9 produces STIM2β. (C) GAPDH-normalized expression levels of STIM2α 
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The inhibition of Ca2+ entry by STIM2β could in principle 
result from a direct effect on the Orai1 channel (inhibition of 
activity or a loss of Ca2+ selectivity), or an indirect effect such 
as membrane depolarization (reduction of the driving force 
for Ca2+ entry). To resolve this question, we used whole-cell 
recording to measure Orai1-mediated CRAC currents (ICRAC) 
induced passively by intracellular dialysis with EGTA through 
the recording pipette. In HEK293 cells stably overexpressing 
STIM1 and Orai1, coexpression of STIM2β-YFP altered the ki-
netics of ICRAC induction (Fig. 3, A and B), resulting in a short-
ened lag phase before current initiation and a reduced maximal 
rate of current development. Importantly, STIM2β coexpression 
reduced the ICRAC density at steady state by ∼60% compared 
with coexpression of YFP only (Fig. 3 C). In contrast, the cur-
rent–voltage relation for ICRAC in 20 mM Ca2+ was unaffected, 
showing normal inward rectification with a lack of a well-de-
fined reversal potential up to approximately +80 mV, consistent 
with the characteristic high selectivity of Orai1 for Ca2+ over 
monovalent cations (Fig. 3 D). STIM2β coexpression also did 
not affect the reversal potential measured in the absence of di-
valent cations (48.6 ± 2.5 mV for YFP and 49.4 ± 4.0 mV for 
STIM2β, mean ± SEM), indicating that STIM2β does not alter 
the relative permeability of the channels to Cs+ and Na+ (Fig. 3 
E). Together, the results of Figs. 2 and 3 show that STIM2β in-
hibits SOCE directly by reducing CRAC channel activity with-
out significantly affecting its ion selectivity.
The 2β insert disrupts the interaction of 
STIM2β with Orai1
To understand how STIM2β inhibits ICRAC, we studied its inter-
action with Orai channels. Coexpression of STIM2α and Orai1 
fully reconstituted SOCE in Neuro2A neuroblastoma cells, a 
SOCE-deficient cell line (Fig. 4 A). In contrast, coexpression 
of STIM2β with Orai1 failed to produce detectable SOCE, 
indicating that the 2β insert disrupts the functional interac-
tion between STIM2β and Orai1.
The CAD/SOAR region of STIM proteins is known to 
be necessary and sufficient to activate Orai channels (Park et 
al., 2009; Yuan et al., 2009). To confirm that the inability of 
STIM2β to activate Orai1 resulted from altered function of 
its CAD, we coexpressed Orai1 with STIM2α- or STIM2β-
CAD. As with the full-length STIM2 proteins, coexpression of 
STIM2α-CAD with Orai1 produced robust increases in [Ca2+]i, 
whereas STIM2β-CAD with Orai1 failed to do so (Fig. 4 B). 
STIM2β-CAD also failed to produce increases in [Ca2+]i 
with Orai2 and Orai3 (Fig. 4, C and D), isoforms that are 
more tolerant of CAD mutations than Orai1 (Frischauf et al., 
2009), further underscoring the complete inability of STIM2β-
CAD to activate Orai channels.
The failure of STIM2β to activate Orai1 could result from 
a deficient response to Ca2+ store depletion or from a more prox-
imate defect in STIM2β–Orai1 coupling, as the CAD region is 
involved in both of these processes (Park et al., 2009; Coving-
ton et al., 2010; Yang et al., 2012). To test whether STIM2β can 
respond to store depletion, we expressed fluorescently tagged 
STIM2 constructs in HEK293 cells and imaged their accumu-
lation at ER–PM junctions as fluorescent puncta. Both STIM2α 
and STIM2β formed puncta in most resting cells even without 
store depletion (Fig. 5 A), consistent with the partial activity 
of STIM2 in resting cells (Fig. 2 E; Brandman et al., 2007). 
In cells expressing low amounts of either isoform, the bright-
ness and number of puncta were increased after store depletion 
with Tg (Fig. 5 A). Quantitative analysis showed that STIM2α 
and STIM2β formed puncta of similar density, area, and in-
tensity (Fig. 5, B and C). Furthermore, in cells coexpressing 
tagged STIM1 and STIM2β, STIM2β puncta coincided pre-
cisely with STIM1 puncta (Fig. S2 A). Thus, STIM2β by itself 
maintains the ability to redistribute to ER–PM junctions in re-
sponse to Ca2+ store depletion.
STIM proteins activate SOCE by first binding and trap-
ping Orai channels at ER–PM junctions (Park et al., 2009; Wu 
et al., 2014). To determine whether STIM2β retains the ability 
to trap Orai1, we coexpressed STIM2α or STIM2β with Orai1 
in HEK293 cells. STIM2α robustly recruited Orai1 into puncta 
as measured by increased Orai fluorescence in puncta and co-
localization with STIM2α. In contrast, STIM2β's recruitment 
of Orai1 was significantly impaired (Fig. 5, B and D). Roughly 
60% of STIM2β puncta showed no accumulation of Orai1, 
while the remainder showed some recruitment (Fig. S2 B), sug-
gesting that STIM2β interacts only weakly with Orai1.
The STIM2β–Orai interaction was quantified by measur-
ing FRET between CFP-Orai1 and YFP-tagged STIM2α- and 
STIM2β-CADs. When coexpressed with CFP-Orai1, YFP-
STIM2α-CAD localized close to the PM (Fig. 5 E) and showed 
substantial FRET (Fig. 5, E and F), indicating significant 
binding between STIM2α-CAD and Orai1. In contrast, under 
similar conditions, STIM2β-CAD maintained a cytosolic distri-
bution and did not generate significant FRET (Fig. 5, E and F; 
and Fig. S4 B), confirming that its binding to Orai1 is disrupted.
Heterodimerization with STIM1 recruits 
STIM2β to Orai1 channels
The weakened binding of STIM2β to Orai1 stands in appar-
ent contradiction to its strong inhibition of SOCE. However, 
STIM1 and STIM2 are known to form heterodimers (Williams 
et al., 2001; Soboloff et al., 2006; Darbellay et al., 2010), which 
could provide a mechanism to recruit STIM2β to Orai channels 
and facilitate inhibition. We used a FRET assay to assess the 
ability of STIM2β to heterodimerize with STIM1. YFP-labeled 
STIM2α- and STIM2β-CADs showed similar levels of FRET 
with CFP-labeled STIM1-CAD (Fig. 6 A), indicating that 
STIM2β-CAD heterodimerizes normally with STIM1-CAD. 
and STIM2β in human tissue RNA samples, measured by quantitative RT-PCR. Means of technical replicates are shown (Ht, heart; Li, liver; Pa, pancreas; 
Th, thymus; Br, brain; Ce, cerebellum; Hp, hippocampus). (D) Sequence alignment of the 2β insert across six mammalian species (also see Fig. S1 A). 
Conservative differences are marked in gray. (E) GAPDH-normalized expression levels of STIM2α (top) and STIM2β (middle) mRNA in differentiating cul-
tured C2C12 myoblasts. An approximately fivefold increase in the STIM2β/STIM2α ratio (bottom) occurs during the first 2 d of differentiation. Error bars 
represent SEM of three independent wells. (F) Domain structure of STIM2. Inclusion of exon 9 leads to an insert (2β, green) in the CAD (SIG, signal peptide; 
EF-SAM, EF hand/sterile-α motif; TM, transmembrane segment; P/H, proline/histidine-rich domain; PBD, polybasic domain). (G) Alignment of partial CAD 
sequences from human STIM1, STIM2α, and STIM2β. Sequence identity and similarity are shown in black and gray, respectively. (H) Predicted structures 
of STIM2α- (center) and STIM2β-CAD (right) derived from the crystal structure of STIM1-CAD (left; Yang et al., 2012) by homology modeling. The stretch 
of basic residues involved in Orai1 binding is highlighted in purple, and the 2β insert is highlighted in red. N and C termini of the front monomer in each 
structure are marked for orientation. a.u., arbitrary unit.
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Similarly, full-length STIM2α- and STIM2β-CFP generated 
comparable levels of FRET with full-length STIM1-YFP (Fig. 
6 B). Lastly, STIM2α- and STIM2β-GFP coimmunoprecipi-
tated to a similar extent with FLAG-STIM1 (Fig. 6 C). Thus, 
STIM2β can heterodimerize with STIM1 to a similar degree as 
STIM2α. Similarly, FRET between STIM2α and STIM2β and 
between their respective CADs (Fig. S3, A and B) indicated that 
STIM2β can also heterodimerize with STIM2α.
To test whether heterodimerization with STIM1 can re-
cruit STIM2β to Orai1 channels, we expressed STIM constructs 
lacking the C-terminal polybasic domain (ΔK) in HEK293 cells 
and depleted Ca2+ stores with Tg. In the absence of the polyba-
sic domain, STIM proteins cannot bind to phosphatidylinosi-
tol 4,5-bisphosphate in the PM, and their trapping at ER–PM 
junctions becomes absolutely dependent on the CAD-medi-
ated interaction with Orai1 (Fig. 6 D, left; Park et al., 2009). 
As expected from the lack of strong binding between STIM2β 
and Orai1, STIM2β-ΔK failed to form puncta when expressed 
with Orai1 alone (Fig. 6 D, left). However, STIM2β-ΔK 
did form distinct puncta when coexpressed with Orai1 and 
STIM1-ΔK (Fig. 6 D, right). This STIM1-ΔK–dependent for-
mation of STIM2β-ΔK puncta (Fig. 6 E) suggests that the in-
teraction between STIM1-ΔK and Orai1 is sufficient to recruit 
STIM2β-ΔK–STIM1-ΔK heterodimers to Orai1. Consistent 
with this result, coexpression of STIM1 led to significantly in-
creased FRET between STIM2β-YFP and CFP-Orai1 (Fig. S3 
C). Thus, heterodimerization with STIM1 (or STIM2α) pro-
vides an essential means of recruiting STIM2β to Orai1 and 
enabling channel inhibition (Fig. 6 F).
The STIM2β insert sequence has a critical 
role in inhibiting SOCE
The high evolutionary conservation of the 2β insert suggests 
that the amino acid sequence itself may be an important func-
tional determinant of STIM2β’s inhibitory activity. To test this 
idea, we made a series of pairwise mutations of its central 
amino acids (Fig. 7 A); the A2D and L2R mutants introduce 
polarity at positions with a strong preference for nonpolar res-
idues (Fig. S1 A), whereas the SYAA mutant removes a pair 
of highly conserved residues in the central part of the insert. 
When expressed with Orai1, all three mutants showed dimin-
ished inhibition of SOCE compared with wild-type STIM2β, 
as assessed by the peak fura-2 ratio after Ca2+ readdition (Fig. 7 
B). Although the SYAA mutant retained ∼75% of the inhibition 
seen with wild-type STIM2β, the A2D and L2R mutations pro-
duced only ∼40% inhibition (Fig. 7 B). These results are mean 
values obtained from cells expressing STIM2β proteins at vary-
ing levels. A closer look at SOCE in single cells as a function of 
STIM2β expression revealed that the L2R and A2D mutations 
were even more effective at diminishing the inhibitory action of 
STIM2β when expressed at low to moderate levels (Fig. 7 C). 
Figure 2. STIM2β inhibits Orai1-mediated 
SOCE. (A and B) Resting cytosolic [Ca2+] 
in HEK293T cells transfected with STIM2α, 
STIM2β, or mCherry (mCh). Frequency distri-
bution (A) and means ± SEM (B) of fura-2 ra-
tios are shown. STIM2β overexpression caused 
a small but significant reduction in the cytosolic 
fura-2 ratio (n > 800 cells for each condition, 
P < 0.0001, Mann–Whitney test). (C and 
D) Resting ER [Ca2+] in HEK293T cells trans-
fected with Orai1 and STIM2β or mCherry. 
Frequency distribution (C) and means ± SEM 
(D) of T1ER emission ratios (see Materials and 
methods) are shown. Higher T1ER ratio signi-
fies higher ER Ca2+ levels. STIM2β overexpres-
sion significantly reduced the T1ER ratio (n > 
5,000 cells for each condition, P < 0.0001, 
Mann–Whitney test). (E) Effects of STIM2α and 
STIM2β on SOCE in HEK293 cells expressing 
Orai1. Solution changes are indicated, with 
extracellular Ca2+ concentration in millimolar. 
STIM2α but not STIM2β elevated resting [Ca2+]
i. After depletion of ER Ca2+ stores with 1 µM 
Tg in Ca2+-free solution, SOCE is shown by the 
response to 2 mM Ca2+. Compared with the 
pcDNA3 control, STIM2α increased SOCE, 
whereas STIM2β strongly inhibited SOCE (n 
> 30 cells for each condition). (F) NFAT ac-
tivity in store-replete (PDBu) or store-depleted 
(PDBu+Tg) HEK293T cells. Overexpression 
of STIM2α but not STIM2β drives constitutive 
NFAT activity in store-replete cells, whereas 
overexpression of STIM2β strongly inhibits 
NFAT activation by store depletion (n = 3 wells 
for each condition). Error bars show means ± 
SEM. a.u., arbitrary unit.
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These results show that the specific sequence of the 2β insert is 
critical for enabling the potent inhibition of SOCE.
We considered several hypotheses to explain how muta-
tions in the 2β insert reduce the ability of STIM2β to inhibit 
SOCE. First, the mutations might lead to misfolding or mislo-
calization of the protein. However, the L2R mutant showed nor-
mal ER localization and puncta formation upon store depletion 
(Fig. S4 A), making such a defect unlikely. A second possibil-
ity is that the mutations inhibit heterodimerization of STIM2β 
with STIM1, thus reducing the amount of STIM2β tethered to 
Orai1 channels and freeing more STIM1 homodimers to ef-
fectively activate SOCE. However, formation of heterodimers 
appeared to be unaffected, as judged by FRET between YFP-
L2R-CAD and CFP-STIM1-CAD (Fig. 7 D and Fig. S4 B). 
Similarly, FRET experiments with covalent heterodimers of 
CAD-containing fragments from STIM1 and STIM2β (referred 
to as S domains; Li et al., 2011; McNally et al., 2013), indicated 
that the L2R mutation does not affect the binding of these het-
erodimers to Orai1 (Fig. 7 E).
A third possibility is that mutations in the 2β insert re-
store the ability of STIM2β to bind and activate Orai1. How-
ever, upon coexpression with CFP-Orai1, YFP-L2R-CAD was 
neither recruited to the PM nor showed significant levels of 
FRET (Fig. 7 F and Fig. S4 B). Furthermore, all three STIM2β 
mutants failed to reconstitute SOCE in Neuro2A cells when co-
expressed with Orai1 (Fig. S4 C). Although these experiments 
rule out the restoration of strong Orai1 binding or activation 
in the mutants, they do not exclude the possibility that muta-
tions in STIM2β restore weak interactions with Orai1, which 
are sufficient to activate Orai1 when the mutants are tethered 
to it as heterodimers with STIM1. To test this possibility, we 
constructed chimeras of Orai1 with a dimer of S domains (Fig. 
7 G). This chimeric system mimics the high local STIM2β 
concentrations created by the binding of STIM2β–STIM1 
heterodimers to Orai1 and also allows STIM2β–Orai1 inter-
action to be measured directly, i.e., without the interference 
of STIM1. Fusion of STIM2α S domains to Orai1 produced 
strong constitutive Ca2+ influx, similar to fusions of STIM1 S 
domains reported previously (Li et al., 2011; McNally et al., 
2013), confirming that the chimeric constructs form func-
tional channels (Fig. 7 H). Chimeras with S domains from a 
STIM2α-KA mutant (KIKKKR → KIAAAR), which cannot 
bind or activate Orai1 when expressed in soluble form (Fig. S5, 
A–C), also showed significant Ca2+ influx (Fig. 7 H), demon-
strating that the chimeric system is sufficiently sensitive to de-
tect even weak activating interactions. Significantly, chimeras 
containing S domains from either wild-type STIM2β or its L2R 
mutant did not produce any detectable Ca2+ influx (Fig. 7 H), 
indicating that mutations in the 2β insert did not restore even 
weak Orai1-activating ability.
These data indicate that mutations in the 2β insert sig-
nificantly reduce the ability of STIM2β to inhibit SOCE and 
that this is not caused by defects in folding or trafficking, im-
paired heterodimerization with STIM1, or restored binding and 
Figure 3. STIM2β reduces CRAC current 
amplitude without altering ion selectivity. 
(A) STIM2β alters the time course of CRAC 
current induction. HEK293 cells stably ex-
pressing STIM1 and Orai1 were transiently 
transfected with either STIM2β-YFP or YFP 
only. Currents were measured at −100 mV 
in 20 mM extracellular Ca2+. Normalized 
(norm.) current density (I/Imax) after break-in 
is shown for single cells expressing STIM2β-
YFP or YFP (representative of 5–7 cells per 
condition). (B) Comparison of averaged traces 
from A. To highlight activation kinetics, traces 
for each cell were shifted along the time axis 
before averaging, such that half-maximal ac-
tivation occurred at t = 0 (n = 5–7 cells per 
condition). The maximal rate of activation (at 
50% of maximal current) was 1.1% s−1 and 
0.3% s−1 for YFP and STIM2β, respectively. (C) 
STIM2β reduces the steady-state amplitude of 
ICRAC (n = 9 cells for each condition, P = 0.01, 
Mann–Whitney test). For each cell, Imax was 
measured as described in A. (D and E) STIM2β 
expression does not affect the I–V relationship 
in 20 mM Ca2+ (D) or divalent-free (DVF) Ring-
er’s solutions (E; mean of 4–6 cells per curve). 
Error bars show means ± SEM. Error bars in 
D and E are comparable to the thickness of 
the curves and are not shown.
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activation of Orai1. To explain the sequence-specific inhibition 
of SOCE by STIM2β, we next considered an active inhibition 
mechanism in which STIM2β delivers an inhibitory signal to 
Orai1 through a sequence-specific interaction.
STIM2β inhibits Ca2+ influx through a 
sequence-specific interaction with Orai1
To test for active inhibition of Orai1 by STIM2β, we used 
Orai1(V102C), a pore mutant that is constitutively ac-
tive in the absence of STIM1 (McNally et al., 2012). The 
Orai1(V102C) channel by itself produced constitutive Ca2+ 
influx when Ca2+ was introduced into the extracellular me-
dium (Fig. 8 B). As expected from the disrupted binding of 
STIM2β homodimers to Orai1, coexpression with STIM2β 
did not inhibit Ca2+ flux through Orai1(V102C) channels 
(Fig. S5 D). To mimic the tethering effect of STIM1–STIM2β 
heterodimers, we constructed chimeras of the STIM2β S do-
main with Orai1(V102C) (Fig. 8 A). [Ca2+]i measurements 
were correlated with surface expression of chimeras at the 
single-cell level using an extracellular HA tag inserted into 
the Orai1(V102C) III–IV loop (see Materials and methods). 
Tethering a dimer of STIM2β S domains to the C terminus 
of Orai1(V102C) significantly suppressed Ca2+ influx (74% 
reduction in dRatio/dt slope). This inhibitory effect was ab-
sent in chimeras made with L2R mutant S domains, consistent 
with the reduced inhibition of SOCE by STIM2β bearing this 
mutation (Fig. 8, B and C). Surface HA staining (Fig. 8 D) in-
dicated that the differences in Ca2+ influx were not caused by 
altered surface expression levels of the chimeras and thus are 
likely to reflect an inhibitory interaction between the STIM2β 
S domain and Orai1(V102C) that is abolished by the L2R mu-
tation. These results indicate that STIM2β delivers an inhib-
itory signal to Orai1 through a sequence-specific interaction, 
thus inhibiting SOCE by an active mechanism.
Discussion
The STIM family of proteins is well recognized as having two 
primary functions: to sense [Ca2+]ER and to activate store-op-
erated channels. Our studies of STIM2β show how the inser-
tion of an eight-residue sequence in the CAD region converts 
STIM2α into a potent inhibitor of Orai, thus creating the first 
inhibitory member of the STIM family. In this way, alternative 
splicing of STIM2 presents a new type of mechanism for tuning 
the magnitude of SOCE to match physiological needs.
STIM2β differs in several fundamental ways from 
STIM2α. Although STIM2α was initially described as a SOCE 
inhibitor (Soboloff et al., 2006), this was later determined to 
be an artifact of overexpression (Parvez et al., 2008). STIM2α 
activates Orai channels less effectively than STIM1 (Bird et 
al., 2009; Wang et al., 2014); thus, in the presence of STIM1 
and limiting amounts of Orai1, overexpressed STIM2α can re-
duce SOCE by competing with STIM1 for binding to Orai1 
channels. When this competition is eliminated, e.g., by the 
simultaneous overexpression of Orai1, STIM2α robustly acti-
Figure 4. STIM2β cannot activate Orai channels. (A) STIM2α but not STIM2β can reconstitute SOCE in Neuro2A cells when coexpressed with Orai1. 
(B–D) STIM2α-CAD, but not STIM2β-CAD, elevates basal [Ca2+]i in Neuro2A cells cotransfected with Orai1 (B), Orai2 (C), or Orai3 (D). Expression levels 
of Orai1, 2, and 3 in B–D are not directly comparable (n ≥ 15 cells for each condition in all panels). Error bars show means ± SEM.
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Figure 5. STIM2β responds normally to store depletion but shows weakened Orai1 binding. (A) STIM2β accumulates at ER–PM junctions upon store deple-
tion. Fluorescent puncta in two representative HEK293 cells expressing either mCherry (mCh)-STIM2α or -STIM2β are shown before (top) and after (bottom) 
store depletion with 1 µM Tg. (B) STIM2α-GFP, but not STIM2β-GFP, recruits mCherry-Orai1 into puncta after store depletion with Tg. (C) STIM2β forms 
puncta to a similar extent as STIM2α. Density (left), area (middle), and intensity (right) of puncta in store-depleted cells were quantified from experiments 
similar to B (n > 15 cells for each bar, P > 0.1 for each comparison, two-tailed t test). (D) Compared with STIM2α, STIM2β shows lower colocalization with 
Orai1 (left, measured as Pearson correlation; P < 0.0001, two-tailed t test) and elicits a lower Orai1 intensity (int.) in puncta (right, P = 0.0002, two-tailed 
t test; n > 15 cells for each bar). Data were compiled from experiments similar to B. (E) Binding of STIM2β-CAD to Orai1 is disrupted. FRET in HEK293 
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vates SOCE (Fig. 2 E; Parvez et al., 2008; Bird et al., 2009). 
In contrast, STIM2β cannot effectively bind or activate Orai 
channels by itself, and it inhibits SOCE even when Orai1 is 
overexpressed, ruling out a simple competitive mechanism as 
an explanation for its inhibitory effect. The opposing effects 
of STIM2α and STIM2β on ER and cytosolic Ca2+ levels 
and NFAT activation further underscore the inhibitory action 
of STIM2β. Together, our results establish a unique role for 
STIM2β among all known STIM isoforms as an inhibitor of 
Ca2+ influx through Orai channels.
How does STIM2β inhibit SOCE? We were initially 
surprised to find that STIM2β binding to Orai1 is disrupted, 
making it unlikely that it interacts as a homodimer with Orai 
channels like the other STIM proteins. However, experiments 
with STIM2β-ΔK (Fig. 6 D) and full-length STIM2β (Fig. S3 
C), as well as S-domain dimers (Fig. 7 E), indicate that het-
erodimerization with STIM1 or STIM2α can tether STIM2β to 
Orai1 channels, thus increasing its local concentration to enable 
it to effectively inhibit Orai1 channels despite its low affinity for 
them. Once STIM2β is recruited to the channel in heterodimeric 
form, there are two broad mechanisms by which it could inhibit 
Orai1. In one case, passive inhibition could result from STIM2β 
occluding STIM binding sites on the channel or sequestering 
STIM1 or STIM2α in heterodimers that interact with the chan-
nel with a lower affinity (Fig. 7 E). In these scenarios, STIM2β 
would reduce the number of active CAD domains bound to the 
channel, which would be expected to limit channel activation 
(Hoover and Lewis, 2011; Li et al., 2011).
A second possible mechanism is active inhibition in 
which STIM2β delivers an inhibitory signal through interac-
tions with Orai1 or Orai1-bound STIM1 or STIM2α. Although 
it is currently impossible to assess inhibition of STIM1/2α ac-
tivity directly (i.e., in the absence of Orai1), our results with 
the Orai1(V102C)-STIM2β chimeras strongly support a mech-
anism in which STIM2β delivers an inhibitory signal to Orai1 
(Fig. 8). The inhibition is sequence specific, as it was greatly 
diminished by mutations in the 2β insert. Interestingly, these 
mutants were still able to inhibit SOCE when expressed at high 
levels, apparently in a sequence-independent way (Fig. 7 C). 
A likely explanation is that at high expression levels, STIM2β 
mutants bind most of the STIM1/2α in the form of heterodi-
mers, which then reduce Orai1 activation through the passive 
mechanism. It should be noted that such passive inhibition is 
unlikely to be significant for wild-type STIM2β under physio-
logical conditions, as STIM2β is generally not expressed at high 
levels compared with STIM1, and, even if it were, the effects of 
the stronger active inhibition would likely dominate.
The 2β insert may exert its inhibitory effect by inter-
acting with Orai1 directly or by altering the conformation 
of STIM2β to generate inhibitory interactions between other 
regions of STIM2β-CAD and Orai1. In either case, we ex-
pect these interactions to exhibit low affinity, as STIM2β by 
itself interacts poorly with Orai1 in FRET or puncta forma-
tion assays (Fig. 5). Our electrophysiology results showed that 
STIM2β diminishes the total current through Orai1 channels 
without affecting their ion selectivity (Fig. 3, C–E). In prin-
ciple, the reduced current could reflect inhibition of channel 
opening or inhibition of ion flow through the open pore. In-
terestingly, Orai1(V102C/A) channels are thought to acquire 
their constitutive activity from the removal of a hydrophobic 
barrier to ion permeation near V102 (McNally et al., 2012; 
Dong et al., 2013; Gudlur et al., 2014). Thus, the ability of 
the tethered STIM2β SS construct to inhibit Ca2+ flux through 
Orai1(V102C) supports the latter possibility, that STIM2β 
inhibits Orai1 by imposing a new barrier to conduction, al-
though additional effects on channel opening cannot be ruled 
out. Further studies of the inhibited state of wild-type Orai1 as 
well as Orai1(V102C) will be needed to define the structural 
basis of the STIM2β–Orai interaction and the changes in the 
pore that underlie the inhibitory allosteric effect.
An intriguing finding from patch–clamp recordings was 
that STIM2β expression altered the kinetics of ICRAC develop-
ment in response to passive store depletion. STIM2β signifi-
cantly shortened the lag phase before current initiation (in some 
cases, a small number of channels were even active at the time 
of break-in), and reduced themaximal rate of current develop-
ment (Fig. 3, A and B). Although multiple factors shape the 
activation kinetics of CRAC channels, the observed effects of 
STIM2β may be attributable to the lower ER Ca2+ affinity of 
STIM2 as compared with STIM1. As a result of this lower af-
finity, STIM2 can respond to even mild store depletion, whereas 
STIM1 requires a higher level of store depletion to be reached 
before it is activated (Brandman et al., 2007; Luik et al., 2008). 
If STIM2β shifts the overall Ca2+ sensitivity of STIM1–STIM2β 
heterodimers toward that of STIM2, this may explain the lack 
of a lag phase and altered kinetics of ICRAC induction observed 
in these cells. A more detailed explanation of these kinetic ef-
fects and their possible relationship to the inhibitory action of 
STIM2β awaits further study.
The widespread expression of STIM2β and its high evolu-
tionary conservation suggests that STIM2β is a physiologically 
important mechanism for modulating SOCE (Fig. 9). The gen-
eration of STIM2β through alternative splicing and STIM2β’s 
ability to actively inhibit Orai have several important implica-
tions for its role as an SOCE modulator. As a result of the ability 
of STIM2β to heterodimerize with STIM2α and actively inhibit 
Orai, even small increases in the STIM2β/STIM2α ratio may 
produce large inhibitory effects. Notably, alternative splicing is 
a particularly effective way of changing this ratio, as it produces 
simultaneous and opposite changes in STIM2β and STIM2α 
levels. Increasing STIM2β through splicing may also reduce 
SOCE levels more rapidly than is possible by down-regulating 
STIM2α transcription, which would be slowed by the long half-
life of STIM2α (>24 h; unpublished data).
The presence of multiple developmental defects (e.g., in 
muscle, tooth enamel, and sweat glands) in patients carrying 
mutations in STIM or Orai genes (Feske, 2010; Nesin et al., 
2014) indicates a broad role for SOCE in regulating develop-
mental processes. Among the best studied of these is the role of 
SOCE in regulating the differentiation of muscle (Stiber et al., 
cells transfected with CFP-Orai1 and YFP-tagged STIM2α- or STIM2β-CAD. Unlike STIM2α-CAD (top), STIM2β-CAD (bottom) shows neither membrane 
recruitment nor significant FRET, indicating marginal binding to Orai1. Averaged line scans across cells (right) show high PM colocalization of Orai1 and 
STIM2α-CAD (n = 8 cells) but poor PM colocalization fo r Orai1 and STIM2β-CAD (n = 7 cells). Positions 0 and 1 represent the opposite edges of each 
cell. (F) Comparison of mean E-FRET between Orai1 and STIM1-, STIM2α-, or STIM2β-CAD from experiments like those in E (n > 18 cells for each bar, P < 
0.0001, Mann–Whitney test). Error bars show means ± SEM.  a.u., arbitrary unit. Bars: (A and B) 10 µm; (E) 5 µm.
 o
n
 July 2, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published June 1, 2015
JCB • VOLUME 209 • NUMBER 5 • 2015662
2008; Darbellay et al., 2010) and neural tissue (Somasundaram 
et al., 2014). We have observed an increase in STIM2β splicing 
during the in vitro differentiation of both muscle (Fig. 1 E) and 
neural (unpublished data) progenitors. This change in splicing 
suggests a possible role for STIM2β in regulating differentiation 
through modulation of SOCE. Differentiation of these tissues is 
known to be accompanied by widespread changes in splicing 
(Hall et al., 2013; Li et al., 2014), including that of key calcium 
signaling components (Brandt and Vanaman, 1994; Tang et al., 
2009). Thus, the up-regulation of STIM2β splicing we have ob-
served may provide an effective way of coordinating the mod-
ulation of SOCE with the changes initiated by global splicing 
programs during development.
Materials and methods
Cell culture, transfections, and solutions
HEK293 and HEK293T cells (ATCC) were cultured in antibiotic-free 
DMEM (Gibco) with l-glutamine and 10% FBS (Invitrogen). Neuro2A 
cells (ATCC) were grown in antibiotic-free Eagle’s minimal essential 
medium (ATCC) with 10% FBS. Jurkat cells (clone E6-1) were cul-
tured in RPMI 1640 with 10% FBS and l-glutamine. C2C12 cells were 
a gift from H. Blau (Stanford University, Stanford, CA) and were main-
tained at low confluency in DMEM with GlutaMAX (Invitrogen) and 
20% FBS. HEK293, HEK293T, and Neuro2A cells were cultured to 
70–80% confluency before transient transfections using Lipofectamine 
2000 (Invitrogen). Transfections were performed using the manufactur-
Figure 6. Heterodimerization with STIM1 
tethers STIM2β to Orai1. (A and B) FRET in 
cells coexpressing CFP-STIM1-CAD with YFP-
STIM2α-CAD or YFP-STIM2β-CAD (A), or 
STIM1-YFP with STIM2α-CFP or STIM2β-CFP 
(B). Both STIM2 isoforms as well as their CADs 
interact with STIM1 (n > 17 cells for each 
bar, P > 0.1 for each comparison, Mann–
Whitney test). (C) STIM2α- or STIM2β-GFP 
coimmunoprecipitate to a similar extent with 
FLAG-STIM1 (FL-STIM1). IP, immunoprecipita-
tion. (D) STIM1-ΔK can tether STIM2β-ΔK to 
Orai1 channels. (left) In store-depleted cells, 
STIM1-ΔK forms puncta only in the presence 
of Orai1 , whereas STIM2β-ΔK cannot form 
puncta even when Orai1 is coexpressed. 
(right) However, coexpression of STIM1-ΔK 
is sufficient to recruit STIM2β-ΔK to puncta in 
store-depleted cells expressing Orai1. Bar, 
10 µm. (E) Comparison of puncta formation 
by STIM2β-ΔK from experiments like those 
in D (n ≥ 10 cells for each bar). Significant 
puncta above background are formed only 
upon coexpression of Orai1 and STIM1-ΔK (P 
< 0.0001, one-way analysis of variance). (F) 
Model of STIM2β tethering to Orai1 through 
heterodimerization with STIM1. STIM2β ho-
modimers accumulate at ER–PM junctions 
through interactions of the polybasic domain 
with the PM (left) but do not interact strongly 
with Orai1. STIM2β-STIM1 heterodimers can 
bring STIM2β into close proximity to Orai1 
through STIM1-mediated binding to the Orai1 
C terminus. PBD, polybasic domain. Error bars 
show means ± SEM.
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er’s protocol, except for ER and cytosolic Ca2+ measurements, in which 
fourfold less Lipofectamine 2000 than recommended was used to min-
imize perturbations to cell health. For imaging experiments, cells were 
transferred to polyornithine-coated glass coverslips or 96-well plates 
and bathed in 2 mM Ca2+ Tyrode’s solution (129 mM NaCl, 5 mM KCl, 
2 mM CaCl2, 1 mM MgCl2, 30 mM glucose, and 25 mM Hepes, pH 
7.4) at 22–25°C unless otherwise specified.
Plasmids and primers
The following primers were used for initial detection of STIM2β (Fig. 1 
A): human S2_forward, 5′-ATGCAGCTAGCTATTGCTAAAGATG-3′, 
and S2_reverse, 5′-TCGTTCTCGTAAACAAGTTGTCAACTC-3′; 
and mouse mS2_forward, 5′-ATGCAGCTAGCCATCGCTAAG-
GACG-3′, and mS2_reverse, 5′-CCGTTCTCGCAAGCACGTG-
GTCAGCTC-3′. These primer sets generate 192- and 168-bp bands 
corresponding to STIM2β and STIM2α, respectively.
Mouse and human STIM2α and STIM2β cDNAs were amplified 
using RT-PCR from total mRNA from C2C12 and HEK293 cells, re-
spectively. STIM2α and STIM2β constructs with C-terminal mCherry, 
GFP, or myc-His tags were generated using Gateway cloning (Life 
Technologies) into destination vectors based on pGW1, EGFP-C1, 
and pCDNA3 vectors, respectively. STIM2α and STIM2β CADs were 
identified by alignment with STIM1-CAD, and constructs with N-ter-
minal mCherry, CFP, or YFP tags were created using Gateway cloning. 
Gateway destination vectors with GFP, CFP, and YFP tags were derived 
from pEGFP/ECFP/EYFP-C1/N1 (Takara Bio Inc.) and driven by cy-
tomegalovirus promoters. Destination vectors with mCherry tags were 
derived from pGW1 vector. QuikChange (Agilent Technologies) mu-
Figure 7. The 2β insert sequence is critical for 
inhibition of SOCE by STIM2β. (A) Sequences 
of the wild type and mutant 2β inserts. Mu-
tated residues are highlighted in red. Residue 
numbering is based on the reference sequence 
in Materials and Methods. (B) STIM2β mutants 
show reduced inhibition of Orai1-mediated 
SOCE in HEK293 cells (n > 38 cells for each 
condition). Wild-type and mutant STIM2β 
constructs were cotransfected with Orai1 in 
HEK293 cells, and the response to Ca2+ read-
dition in mCherry cells indicates the full level 
of SOCE mediated by endogenous STIM. (C) 
Peak fura-2 ratios plotted against STIM2β ex-
pression levels in single cells from the experi-
ments shown in B. The dashed line indicates 
the mean peak ratio in mCherry (mCh)-ex-
pressing control cells. a.u., arbitrary unit. (D) 
The L2R mutation does not reduce STIM2β 
heterodimerization with STIM1. YFP-tagged 
CADs from the STIM2β-L2R mutant and wild-
type STIM2β interact similarly with CFP-STIM1-
CAD as shown by FRET (n > 25 cells for each 
bar, P = 0.1384, Mann–Whitney test). (E) The 
L2R mutation does not affect the binding of 
STIM1–STIM2β heterodimers to Orai1. FRET 
was measured between YFP-tagged tandem 
S-domain heterodimers and CFP-Orai1. Both 
wild-type and L2R mutant STIM2β heterodi-
mers show similar levels of Orai1 binding (n 
≥ 13 cells per bar, P = 0.64, Mann–Whitney 
test). (F) The L2R mutation does not restore 
STIM2β binding to Orai1. YFP-tagged CADs 
from the L2R mutant or wild-type STIM2β in-
teract poorly if at all with CFP-Orai1 (n > 12 
cells for each bar, P = 0.7783, Mann–Whit-
ney test). (G) Chimeric system for detecting 
activating interactions. A dimer of S domains 
is covalently tethered to Orai1 channels. As a 
result of its high local concentration, any acti-
vating interactions between the SS dimer and 
Orai1 are detected as constitutive Ca2+ influx. 
(H) Fusion of SS dimers from wild-type STIM2α 
or the STIM2α-KA mutant to Orai1 evokes con-
stitutive Ca2+ influx upon exposure to 2 mM 
Ca2+. Influx is inhibited by 10 µM La3+, con-
sistent with Orai1 activity. In contrast, fusion 
of S-domain dimers from wild-type STIM2β 
or the L2R mutant STIM2β to Orai1 fails to 
elicit Ca2+ influx (n > 16 cells for each curve). 
Error bars show means ± SEM.
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tagenesis was used to generate STIM2α or STIM2β mutants. STIM2β 
S domain dimers were based on previously published STIM1 S do-
mains (Li et al., 2011) and consisted of residues E427–P472 joined 
with a 24-residue linker (GGSGGSGGGILQSTGGSGGSGGSG; see 
primer sequences below; residue numbers based on reference sequence 
below). Orai1 or Orai1(V102C) was cloned between the NheI and XhoI 
sites of the pEYFP-N1 vector downstream of a cytomegalovirus pro-
moter, and STIM2α or STIM2β S-domain dimers were then inserted 
Figure 8. STIM2β inhibits Orai1 channels through a sequence-specific interaction. (A) Chimeric system for detecting inhibitory interactions. A dimer of S 
domains is covalently attached to constitutively active Orai1(V102C). Inhibitory interactions between the S domains and Orai are detected by a reduced 
rate of constitutive Ca2+ influx. (B) Constitutive Ca2+ influx in HEK293 cells expressing Orai1(V102C) or Orai1(V102C)-SS chimeras, measured upon 
addition of 2 mM Ca2+ (n > 45 cells for each curve). (C) The relative Ca2+ influx rates from the experiments in B, quantified by the initial slopes of the 
fura-2 ratio. Fusion of wild-type (P < 0.0001), but not L2R mutant (P = 0.67), STIM2β S domains to Orai1(V102C) strongly inhibited constitutive Ca2+ entry 
(Mann–Whitney test). (D) The cumulative frequency distribution of surface HA intensities for the cells analyzed in B and C shows that surface expression for 
all three channel constructs was similar. a.u., arbitrary unit. Error bars show means ± SEM.
Figure 9. Proposed model for modulation of SOCE by alternative splicing of STIM2. Under conditions of low STIM2β splicing, STIM1 and STIM2α ef-
fectively activate Orai1 channels and enable a high level of SOCE. Up-regulation of STIM2β splicing, e.g., during cell differentiation or in response to 
environmental cues, promotes the formation of STIM2β heterodimers, which inhibit Orai function through a sequence-dependent interaction to reduce the 
capacity for SOCE. Reversal of this process may occur through down-regulation of STIM2β splicing and degradation of existing STIM2β.
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between the Xho1 and BamH1 sites to produce YFP-tagged chimeric 
constructs with a 13-residue linker (LEGVSTATMGGSG). STIM1 and 
Orai1 constructs used here have been previously described (Park et 
al., 2009; Covington et al., 2010). Flag-Myc-Orai1, mCherry-Orai1, 
Flag-Myc-Orai2, mCherry-Orai3, and FLAG-STIM1 were generated 
by Gateway cloning into destination vectors based on the pGW1 back-
bone (New England Biolabs, Inc.).
Primers for Gateway entry clones of STIM2α/β (full length and CAD) 
were as follows: (human) huSTIM2_forward, 5′-ATGAACGCAGCCG-
GGATCAGAG-3′, huSTIM2_reverse, 5′-TCACTTAGATTTCTTCT-
TAAAAAGGCTTTTG-3′, huSTIM2_CAD_forward, 
5′-ATGTCTGTTCCAGATGCACTTCAGAAATGG-3′, and huS-
TIM2_CAD_reverse, 5′-TCAGGTCAGGCTGGGGAGTCC-3′; 
(mouse) msSTIM2_forward, 5′-GCCACCATGAACGCGGCGGC-
GAGCCGAGCTTCGCGGGCC-3′, msSTIM2_reverse, 5′-TCACT-
TAGACTTCTTCTTGAAAAGGCTTTTGATTTTGG-3′, msS2CAD_forward, 
5′-ATGTCTGTCCCTGACGCACTACAGAAATGG-3′, and msS-
2CAD_reverse, 5′-TCAGGTGAGACTGGGGAGCCCAGA-3′.
Primers for cloning STIM2α/β S domains for 
chimeric constructs were as follows: Xho1_msS-
TIM2_S_forward, 5′-GAGCTCGAGGGGGTATCAACCGCCAC-
CATGGGTGGTTCCGGCGAACTGAGAAGCAGCTGGTCTGTC-3′; 
EcoR1_msSTIM2_S_reverse, 5′-GGGGAATTCCACCTCCGC-
TACCTCCAGAGCCGCCGGGTGTGTCTTCATCGAGGTCATC-3′; 
Sal1_msSTIM2_S_forward, 5′-GAGGTCGACGGGTGGTTCCGGT-
GGGTCCGGCGGTTCCGGCGAACTGAGAAGCAGCTGGTCT-3′; 
and BamHI_msSTIM2_S_reverse, 5′-GGGGGATCCGCACCTCCGC-
TACCTCCAGAGCCGCCGGGTGTGTCTTCATCGAGGTCATC-3′.
STIM2α residue numbers referred to in various constructs 
are based on the following reference STIM2α sequence: MNAA-
GIRAPEAAGADGTRLAPGGSPCLRRRGRPEESPAAVVAPR-
GAGELQAAGAPLRFHPASPRRLHPASTPGPAWGWLLRRRR-
WAALLVLGLLVAGAADGCELVPRHLRGRRATGSAATAAS-
SPAAAAGDSPALMTDPCMSLSPPCFTEEDRFSLEALQTIH-
KQMDDDKDGGIEVEESDEFIREDMKYKDATNKHSHLHRED-
KHITIEDLWKRWKTSEVHNWTLEDTLQWLIEFVELPQYEKN-
FRDNNVKGTTLPRIAVHEPSFMISQLKISDRSHRQKLQL-
KALDVVLFGPLTRPPHNWMKDFILTVSIVIGVGGCWFAY-
TQNKTSKEHVAKMMKDLESLQTAEQSLMDLQERLEKAQEEN-
RNVAVEKQNLERKMMDEINYAKEEACRLRELREGAECEL-
SRRQYAEQELEQVRMALKKAEKEFELRSSWSVPDALQK-
WLQLTHEVEVQYYNIKRQNAEMQLAIAKDEAEKIKKKRST-
VFGTLHVAHSSSLDEVDHKILEAKKALSELTTCLRERLFR-
WQQIEKICGFQIAHNSGLPSLTSSLYSDHSWVVMPRVSIPPYP-
IAGGVDDLDEDTPPIVSQFPGTMAKPPGSLARSSSLCRSRR-
SIVPSSPQPQRAQLAPHAPHPSHPRHPHHPQHTPHSLPSPDP-
DILSVSSCPALYRNEEEEEAIYFSAEKQWEVPDTASECDSLNS-
SIGRKQSPPLSLEIYQTLSPRKISRDEVSLEDSSRGDSPVTVD-
VSWGSPDCVGLTETKSMIFSPASKVYNGILEKSCSMNQLSS-
GIPVPKPRHTSCSSAGNDSKPVQEAPSVARISSIPHDLCHNGEK-
SKKPSKIKSLFKKKSK (833 amino acids).
mRNA expression analysis
For expression analysis of C2C12 cells (Fig. 1 E), differentiation 
was initiated by growing cells to 70–80% confluency and then trans-
ferring them to differentiation media. At the required time points, 
cells were lysed, and total RNA was extracted using the RNeasy kit 
(QIAGEN). For expression analysis of human tissues (Fig. 1 C), total 
RNA was purchased from the BioChain Institute. For Fig. 1 A, total 
RNA was extracted from Jurkat and C2C12 cells using the TRIzol 
reagent (Life Technologies).
Total RNA was subjected to DNase digestion and reverse tran-
scription (SuperScript III reverse transcription kit; Life Technologies) 
to obtain cDNA. Quantitative RT-PCR was performed using the SYBR 
green system (Roche) on a thermocycler (RealPlex4; Eppendorf). Iso-
form-specific primers were used to quantify STIM2α and STIM2β, 
with GAPDH primers used as normalization controls. For C2C12 cells, 
the differentiation marker MyoG was also quantified to monitor prog-
ress of differentiation. The ratio of STIM2β and STIM2α was calcu-
lated directly by subtracting cycle threshold values for STIM2α from 
those of STIM2β for the same sample.
Coimmunoprecipitation
HEK293T cells (500,000 per well) were transfected with FLAG-STIM1 
and STIM2α-GFP or STIM2β-GFP. After 24 h, cells were washed 
twice with PBS and then lysed in lysis buffer (50 mM Tris-HCl, pH 
7.5, 150 mM NaCl, 1% Triton X-100, and protease inhibitor cocktail). 
Lysates were centrifuged at 12,000 rpm for 10 min, and the supernatant 
was incubated with anti-FLAG M2 agarose beads (Sigma-Aldrich) for 
4–12 h at 4°C to collect immunoprecipitate. Cell lysates and immuno-
precipitates were analyzed by Western blotting using anti-FLAG (M2 
mouse monoclonal; Sigma-Aldrich) or anti-GFP (rabbit polyclonal; 
MBL International) antibodies.
Structural modeling
De novo secondary structure predictions for the CAD regions of 
STIM2α and STIM2β were made using COILS (http://embnet.vital-it.
ch/software/COILS_form.html). Homology modeling of the 3D struc-
ture of STIM2α/β CAD domains was performed using the Phyre2 
server (http://www.sbg.bio.ic.ac.uk/phyre2). The available crystal 
structure of the STIM1 CAD (PDB accession no. 3TEQ) was selected 
as the best fit among the models suggested by Phyre2, and structures of 
the STIM2α and STIM2β CAD were generated accordingly. Structures 
were displayed in PyMOL (Schrödinger).
Electrophysiology
ICRAC was recorded from tetracycline-inducible HEK293 cells ex-
pressing equal amounts of mCherry-STIM1 and myc-Orai1 protein 
(Sadaghiani et al., 2014). Cells were transiently transfected with 
either STIM2β-YFP or control cytosolic YFP plasmid 2 d before 
recording. STIM1 + Orai1 expression were induced with 1 µg/ml tetra-
cycline 1 d before recording.
Whole-cell voltage clamp recordings were made using an am-
plifier (Axopatch 200B; Molecular Devices) interfaced to an ITC-16 
input/output board and a computer running custom Igor routines devel-
oped in house. The time course of ICRAC induction in response to pas-
sive ER store depletion was monitored in 20 mM Ca2+ Ringer’s using 
a step-ramp stimulus (100-ms step to −100 mV followed by a 100-ms 
ramp to 100 mV) applied at 5-s intervals from a holding potential of 30 
mV. After ICRAC reached steady-state, stimuli were delivered every 2 s 
to monitor current in 20 mM Ca2+, divalent-free (DVF), or 2 mM Ca2+ 
+ 100 µM LaCl3 (for leak subtraction). Solutions were perfused locally 
using a perfusion pencil coupled to an eight-channel electronic valve 
controller (AutoMate Scientific).
2 mM Ca2+ Ringer’s solution contained (mM): 155 NaCl, 4.5 
KCl, 2 CaCl2, 1 MgCl2, 10 d-glucose, and 5 Hepes (pH 7.4 with 
NaOH). 20 mM Ca2+ Ringer’s was similar to 2 mM Ca2+ Ringer’s 
but with 130 mM NaCl and 20 mM CaCl2. DVF Ringer’s contained 
(mM): 150 NaCl, 10 2-hydroxyethyl EDTA, 1 EDTA, 10 tetraeth-
ylammonium-Cl, and 10 Hepes (pH 7.4 with NaOH). Internal (pipette) 
solution contained (mM): 150 Cs aspartate, 8 MgCl2, 10 EGTA, and 
10 Hepes (pH 7.2 with CsOH).
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To compare I/V curves among cells, ramp currents were leak 
subtracted and normalized to the peak inward current at −100 mV. 
ICRAC time courses were normalized to the maximal steady-state current 
at −100 mV and fit to a sigmoid function in Igor Pro (f(t) = base + max/
{1 + exp[(t1/2 − t)/rate])} to obtain t1/2, the time at half-maximal current. 
The maximal rate of ICRAC induction was determined by fitting a line to 
a 20-s time segment of the ICRAC trace centered at t1/2. The current was 
well described by a straight line within this time window.
NFAT luciferase assays
NFAT luciferase assays were performed using the Dual-Luciferase 
Assay kit (Promega). HEK293T cells (∼250,000 per well) were trans-
fected with NFAT-luciferase reporter (firefly luciferase driven by a 
4×-NFAT binding site from the IL-2 promoter) and a control Renilla 
luciferase plasmid (pRLTK; Renilla expression driven by a thymidine 
kinase promoter) along with STIM2α or STIM2β. 16 h after transfec-
tion, cells were stimulated with 1 µM PDBu (LC Laboratories) with 
or without 1 µM Tg (LC Laboratories) for 6 h and lysed using passive 
lysis buffer (Promega). NFAT luciferase activity was quantified as the 
ratio of firefly to Renilla luciferase activity measured using a 96-well 
automated luminometer (Turner BioSystems).
Confocal microscopy
HEK293 cells were transfected with 100–150 ng of fluorescently 
tagged STIM and Orai constructs and imaged 12–15 h after transfec-
tion. For imaging store depletion-mediated translocation of STIM2α 
and STIM2β, live cells were imaged before and 10 min after treatment 
with 1 µM Tg at 22–25°C. For quantifying maximal puncta formation, 
cells were fixed with 4% PFA and 8% sucrose in PBS immediately after 
Tg treatment. Cell footprints were imaged with the confocal micro-
scope (UltraVIEW VoX; PerkinElmer) using a 63× Plan Apochromat 
(NA 1.4) oil immersion objective (Carl Zeiss).
For quantification of puncta, regions of interest (ROIs) were 
drawn manually just inside the cell edge and analyzed using the Voloc-
ity software package (PerkinElmer). Pearson correlation coefficients 
between STIM and Orai were calculated for the entire ROI. Puncta 
were identified as regions with STIM intensity greater than three stan-
dard deviations above the cell mean (using Volocity’s “identify objects 
based on intensity” function). STIM and Orai intensity within each 
punctum was quantified in Volocity, and mean puncta number, area, 
and intensities were calculated using MATLAB (MathWorks).
Resting ER and cytosolic Ca2+ measurements
For ER Ca2+ measurements, HEK293T cells were transfected with 
pcDNA3-T1ER (Bandara et al., 2013) along with mCherry or mCher-
ry-tagged STIM2 constructs. After 40–48 h, cells were plated on 96-
well plastic bottom plates (Costar) and imaged using an automated 
epifluorescence microscope (ImageXpress Micro XL; Molecular De-
vices) with a 10× objective (NA 0.3) at 37°C. Images were acquired 
for CFP (excitation = 430 ± 12 nm; emission = 480 ± 20 nm), YFP 
(excitation = 500 ± 10 nm; emission = 535 ± 15 nm), FRET (excitation 
= 430 ± 12 nm; emission = 535 ± 15 nm), and mCherry channels. After 
subtracting background fluorescence, FRET/CFP emission ratios were 
calculated within single cells identified by the thresholded mCherry 
image. All image processing was performed in MATLAB.
For cytosolic Ca2+ measurements, HEK293T cells were plated 
on 96-well glass-bottom plates (In Vitro Scientific) and loaded with 
1 µM fura-2/AM (Invitrogen) for 30–45 min at 37°C in serum-free 
media. Cells were washed with Tyrode’s solution and imaged using 
an automated epifluorescence microscope (ImageXpress 5000A; Mo-
lecular Devices) with a 10× objective (NA 0.3) at 37°C. Images were 
acquired for fura-2 (excitation = 340 ± 6 nm or 380 ± 6 nm; emission 
= 510 ± 40 nm) and mCherry (excitation = 565 ± 27; emission = 650 ± 
37). Fura-2 340/380 ratios were calculated within single cells identified 
by the thresholded mCherry image.
Calcium imaging
HEK293 or Neuro2A cells on glass coverslips were loaded with 1 µM 
fura-2/AM in serum-free media for 30 min at 37°C and then washed 
with Tyrode’s solution before imaging. For experiments with Orai1–S-
domain chimeras, cells were incubated in Ca2+-free Tyrode’s solution 
(CaCl2 replaced with MgCl2) for 15–30 min to restore [Ca2+]i in all 
cells to a low baseline before imaging. Coverslips were mounted in 
perfusion chambers and imaged using 340- and 380-nm excitation with 
an inverted microscope (Eclipse 2000-U; Nikon) equipped with 40× 
Nikon Fluor (NA 1.3) oil immersion objective, xenon arc lamp (Sutter 
Instrument), excitation filter wheel (Lambda-10; Sutter Instruments), 
and a charge-coupled device camera (Orca; Hamamatsu Photonics). 
Manual perfusion through syringes was used to exchange extracellu-
lar solutions. Transfected cells were identified using mCherry or YFP 
fluorescence, and ROIs were drawn manually. Mean fura-2 340/380 
ratio within each ROI was quantified using custom scripts in Openlab 
(PerkinElmer). Igor Pro (WaveMetrics) and Prism 6 (GraphPad Soft-
ware) were used for data analysis and plotting.
Correlated Ca2+ imaging and surface HA staining
HEK293 cells were transfected with Orai1 constructs having a HA tag 
inserted into the extracellular III–IV loop. After collection of Ca2+ im-
aging data, the cells were immediately fixed using 4% PFA and 8% su-
crose in standard PBS. To measure Orai expression on the cell surface, 
cells were stained without permeabilization using monoclonal anti-HA 
antibody (3F10; Roche) followed by Alexa Fluor 594–coupled anti–rat 
secondary antibody (both at 1:1,000 dilution; Life Technologies), and 
imaged using the same microscope used for Ca2+ imaging. Fiduciary 
markings on the coverslips were used to identify the cells that were an-
alyzed by Ca2+ imaging and to correlate HA staining with [Ca2+]i at the 
single-cell level. Custom scripts in MATLAB were used to calculate 
slopes from the fura-2 340/380 ratio traces of selected cells.
FRET measurements
FRET measurements were made using the three-cube E-FRET method 
(Zal and Gascoigne, 2004). HEK293 cells expressing CFP- and YFP-
tagged constructs were plated on glass coverslips and imaged 30–48 h 
after transfection using an inverted epifluorescence microscope (Ax-
iovert 200M; Carl Zeiss) with a 40× Fluar (NA 1.3) oil immersion 
objective (Carl Zeiss) and a polychrome II excitation source (TILL 
Photonics). Three channels were acquired (all filters obtained from 
Chroma Technology Corp.): CFP (440 ± 10 nm excitation, 455 DCLP 
dichroic, and 485 ± 20 nm emission), YFP (500 ± 10 nm excitation, 
515 DCXR dichroic, and 535 ± 15 nm emission), and FRET (440 ± 
10 nm excitation, 455 DCLP dichroic, and 535 ± 15 nm emission). For 
FRET experiments between STIM2α and STIM2β (Fig. S3, A and B), 
imaging was conducted at 20× magnification on a microscope (Imag-
eXpress Micro XL) described above (see section on Resting ER and 
cytosolic Ca2+ measurements). 
CFP, YFP, and FRET images were analyzed using a custom-writ-
ten script in MATLAB. For FRET experiments with CFP-Orai1, ROIs 
were drawn manually along the cell membrane as identified by high 
CFP-Orai1 fluorescence. For STIM–STIM or CAD–CAD FRET ex-
periments, ROIs were drawn randomly in the cytosolic regions of each 
cell. To avoid bias, only the CFP and YFP channels were visualized 
during ROI selection. Analysis was limited to cells showing YFP/
CFP fluorescence ratios between 0.4 and 4 for all conditions to ensure 
accurate comparisons of E-FRET values. E-FRET was calculated as 
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E-FRET = Fc/(Fc + G IDD), where Fc = IDA − a (IAA − c IDD) − d (IDD 
− b IAA), and IDD, IAA, and IDA are the background-corrected intensi-
ties in the CFP, YFP, and FRET channels, respectively. G is the instru-
ment-dependent correction factor, and a, b, c, and d are bleedthrough 
factors calculated using cells expressing only YFP or CFP constructs 
(Zal and Gascoigne, 2004). Fixed cells expressing the calibrator con-
struct CFP-RPTPα-SpD2-YFP2.1 (Blanchetot et al., 2002) were used 
to calculate G to estimate the degree of donor quenching from sensi-
tized emission measurements.
Statistics
All statistical analysis was performed in Prism 6 (GraphPad Soft-
ware) or the GraphPad QuickCalcs website (http://www.graphpad.
com/quickcalcs/). All error bars represent SEM. All pairwise dif-
ferences were tested for significance using a nonparametric two-
tailed Mann–Whitney test or a two-tailed t test. Exact p-values are 
reported wherever possible.
Online supplemental material
Fig. S1 shows alignment of STIM2β insert sequence across multi-
ple species and predicted effects of the 2β insert on coiled-coil for-
mation in CAD. Fig. S2 shows further analysis of puncta formation 
and Orai1 recruitment by STIM2α and STIM2β. Fig. S3 shows FRET 
experiments between STIM2α and STIM2β and the effect of STIM1 
on FRET between STIM2β and Orai1. Fig. S4 shows characterization 
of the STIM2β-L2R mutant. Fig. S5 shows characterization of the 
STIM2α-KA mutant and the lack of inhibitory effect of independently 
expressed STIM2β on Orai1(V102C). Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201412060/DC1.
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